8 min read
Monthly FDA Guidance and Regulatory News Review - August 2026
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...
Where Biotech Innovation Meets the Path Forward
BIOSPAIN 2026: September 29- October 1, 2026 – Bilbao, Spain
Veristat is pleased to attend BIOSPAIN 2026, bringing together biotechnology companies, researchers, investors, and industry leaders to connect around the science and innovation shaping the future of healthcare. As one of Europe’s leading biotechnology events, BIOSPAIN creates an important forum for new ideas, strategic partnerships, and the next generation of therapies.
We’re looking forward to connecting with biotech leaders in Bilbao to discuss how promising science can move efficiently through development. Veristat combines regulatory strategy, clinical development, biometrics, and medical writing expertise to help sponsors make informed decisions, navigate complex requirements, and advance programs toward meaningful regulatory and patient milestones.
Meet with Us
Connect with us at the event to explore how Veristat’s scientific leadership and focused capabilities can help advance your clinical and regulatory milestones.
Balma Gil, Business Development Director
Schedule a Meeting in Advance
Complete the form on this page to reserve time with our team. We welcome the opportunity to learn about your upcoming programs and explore how Veristat can support your development strategy.
Our Expertise
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:
- Clinical Operations Excellence
- Global Regulatory Strategy & Submissions
- Full-Service Clinical Development Solutions
If you’ll be at the meeting, let’s make time to discuss how we can help move your programs forward.
Schedule A Meeting
Meet with us at BIOSPAIN 2026 by filling out the form below.
8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...